H0770B4403A07625 NAD:CDM 10/14/20 #90 A07625
AMENDMENTS TO HOUSE BILL NO. 770
Sponsor: SENATOR J. WARD
Printer's No. 4403
Amend Bill, page 1, line 8, by inserting after "supervision"
and for laboratory waiver
Amend Bill, page 2, by inserting between lines 17 and 18
(23) "COVID-19" means the novel coronavirus as identified in
the proclamation of disaster emergency issued by the Governor on
March 6, 2020, published at 50 Pa.B. 1644 (March 21, 2020).
Amend Bill, page 2, line 18, by striking out "a section" and
inserting
sections
Amend Bill, page 5, by inserting between lines 20 and 21
Section 9.5. Laboratory Waiver.--If a pharmacy holds a valid
certificate of waiver issued by the Centers for Medicare and
Medicaid Services, a pharmacy or pharmacist may order and
perform laboratory examinations and procedures for COVID-19,
influenza and streptococcal infections authorized or approved by
the United States Food and Drug Administration under the
Clinical Laboratory Improvement Amendments of 1988 (Public Law
100-578, 102 Stat. 2903) and shall be exempt from the
requirements under section 3 of the act of September 26, 1951
(P.L.1539, No.389), known as "The Clinical Laboratory Act."
Amend Bill, page 5, line 28, by striking out "in 60 days."
and inserting
as follows:
(1) The following provisions shall take effect
immediately:
(i) The addition of section 9.5 of the act.
(ii) This section.
(2) The remainder of this act shall take effect in 60
days.
2020/90NAD/HB0770A07625 - 1 -
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29